14.3 Endocrine Emergencies: Hypoglycemia, DKA/HHS & Glucagon/Dextrose Administration

14.3 Endocrine Emergencies: Hypoglycemia, DKA/HHS & Glucagon/Dextrose Administration

Physiology of Glucose Regulation & Cellular Metabolism

Glucose is the primary obligate metabolic fuel for the human central nervous system. The brain consumes approximately 120 grams of glucose daily (accounting for ~60% of total whole-body glucose utilization at rest). Because cerebral neurons cannot synthesize glucose, store glycogen in significant quantities, or utilize free fatty acids for energy, uninterrupted neurological function depends on continuous circulating blood glucose maintenance within a tight physiological range (4.0 to 7.0 mmol/L [72 to 126 mg/dL] fasting).

Endocrine homeostasis is maintained by pancreatic islets of Langerhans:

• Beta Cells & Insulin: High plasma glucose triggers insulin secretion. Insulin is an anabolic hormone that binds tyrosine kinase receptors, mobilizing GLUT4 glucose transporters to cell membranes in skeletal muscle and adipose tissue. It stimulates glycogenesis, lipogenesis, and protein synthesis while potently inhibiting glycogenolysis, gluconeogenesis, lipolysis, and ketogenesis.
• Alpha Cells & Glucagon: Hypoglycemia suppresses insulin and stimulates glucagon release. Glucagon binds G-protein coupled receptors in hepatocytes, activating adenylyl cyclase to elevate cAMP and protein kinase A. This stimulates hepatic glycogenolysis (hydrolysis of stored glycogen into glucose) and gluconeogenesis (synthesis of glucose from lactate, glycerol, and amino acids), raising circulating blood glucose levels.

---

Acute Hypoglycemia: Neuroglycopenia vs Adrenergic Surges

Under Canadian paramedic clinical guidelines (CPCF Appendix A #4, #5), acute hypoglycemia is defined as a capillary blood glucose reading <4.0 mmol/L (<72 mg/dL) accompanied by characteristic clinical signs.

Clinical Presentation: Adrenergic vs Neuroglycopenic Signs

As plasma glucose drops, two distinct physiological cascades occur:

1. Autonomic / Adrenergic Signs (Threshold: <3.8 to 3.3 mmol/L): Initiated by a massive sympathoadrenal surge of epinephrine, norepinephrine, and acetylcholine designed to alert the individual to feed and stimulate hepatic glucose release. Signs include diaphoresis, pallor, piloerection, tremors, tachycardia, palpitations, anxiety, and intense hunger (polyphagia). Note: Patients receiving non-selective beta-blockers (e.g., propranolol) or those with long-standing diabetes suffering from hypoglycemia unawareness (autonomic neuropathy) will not mount these warning adrenergic signs.
2. Neuroglycopenic Signs (Threshold: <2.8 mmol/L): Direct cellular fuel starvation of cerebral cortical and subcortical neurons. Manifests as irritability, behavioral changes, confusion, drowsiness, ataxia, visual disturbances, seizures, coma, and focal neurological deficits (hemiparesis, aphasia) that perfectly mimic acute ischemic stroke.

[!IMPORTANT] The Stroke Mimic Rule: Every patient presenting with altered mental status, confusion, acute focal neurological deficits, or seizures must receive an immediate point-of-care capillary blood glucose measurement. Hypoglycemia is the single most common reversible stroke mimic in prehospital care. Transporting a hypoglycemic patient under a stroke bypass protocol without checking blood glucose is a critical clinical error.

---

Prehospital Pharmacotherapy for Hypoglycemia

Paramedics employ a tiered pharmacological approach tailored to the patient's level of consciousness and airway protective reflexes:

Hypoglycemia Prehospital Decision Tree (Blood Glucose <4.0 mmol/L):
1. Conscious, Alert, Intact Gag & Swallow Reflex:
   -> Administer 15–20 g of Oral Glucose Gel (or equivalent fast-acting carbohydrates).
   -> Recheck blood glucose in 15 minutes.
2. Altered Mental Status, Impaired Swallowing, Unconscious, or IV Access Available:
   -> First-Line: 10% Dextrose in Water (D10W) 100–250 mL (10–25 g) IV titrated infusion.
   -> Alternative: 50% Dextrose in Water (D50W) 25–50 mL (12.5–25 g) slow IV push in large vein.
3. Altered Mental Status / Unconscious AND IV Access Cannot Be Established:
   -> Administer Glucagon 1.0 mg IM (0.5 mg in pediatrics <20 kg).
   -> Continue attempts at IV access while awaiting glucagon action (8–15 minutes).

1. Oral Glucose Gel

• Dose: 15 to 20 grams orally.
• Requirement: The patient must be awake, cooperative, able to sit upright, and demonstrate a preserved swallow reflex. It is administered by having the patient swallow the gel or by applying it to the buccal mucosa if conscious. Never administer oral agents to an obtunded patient due to severe aspiration pneumonia risks.

2. Intravenous Dextrose: D10W vs D50W

• 10% Dextrose in Water (D10W): Modern Canadian paramedic protocols strongly favor D10W over D50W. D10W provides 10 grams of dextrose per 100 mL. Paramedics infuse 100 mL to 250 mL (10 to 25 g) titrated to mental status recovery.
  • Why D10W is Superior: D50W is extremely hypertonic (~2,525 mOsm/L), whereas D10W has an osmolarity of ~505 mOsm/L. Extravasation of D50W into subcutaneous tissue causes severe chemical irritation, tissue necrosis, compartment syndrome, and ulceration requiring surgical grafting. Furthermore, D50W inflicts sudden hyperosmolar spikes, rebound hyperglycemia, and post-treatment hypoglycemia, whereas D10W allows gentle, controlled titration to normoglycemia.
• 50% Dextrose in Water (D50W): Administered as 25 to 50 mL (12.5 to 25 g) via slow IV push. Requires a free-flowing, large-bore intravenous catheter with mandatory continuous blood aspiration before and during administration to guarantee intravascular placement.

3. Intramuscular Glucagon

• Dose: 1.0 mg IM for adults (0.5 mg for pediatrics <20 kg).
• Mechanism: Stimulates hepatic adenylate cyclase to convert stored liver glycogen into glucose (glycogenolysis).
• Critical Limitations: Glucagon relies entirely on pre-existing hepatic glycogen reserves. It is clinically ineffective in patients suffering from:
  • Chronic alcohol use disorder (alcohol metabolism blocks gluconeogenesis and depletes liver glycogen).
  • Severe malnutrition, cachexia, or prolonged fasting.
  • Advanced end-stage liver cirrhosis.
  • Neonates and infants with limited glycogen stores.
• Furthermore, glucagon requires 8 to 15 minutes to elevate blood glucose, unlike intravenous dextrose which acts within 1 to 3 minutes.

---

Diabetic Ketoacidosis (DKA) vs Hyperosmolar Hyperglycemic State (HHS)

Severe decompensated hyperglycemia represents a continuum of life-threatening metabolic crises arising from absolute or relative insulin deficiency.

Pathophysiological Cascades: Ketogenesis vs Hyperosmolality

• DKA Ketogenesis Cascade: In absolute insulin deficiency, glucose cannot enter peripheral cells. The body perceives cellular starvation and unleashes unrestrained lipolysis via hormone-sensitive lipase. Adipose tissue floods the liver with free fatty acids. In the liver, glucagon accelerates carnitine palmitoyltransferase-1 (CPT-1) activity, shunting fatty acids into mitochondrial beta-oxidation to produce excessive ketone bodies: beta-hydroxybutyrate and acetoacetate. These organic ketoacids dissociate, releasing hydrogen ions that overwhelm bicarbonate buffering, creating severe metabolic acidosis. Acetone is excreted via the lungs, generating a distinct fruity or sweet breath odor.
• Kussmaul Respirations: The medullary respiratory center senses severe metabolic acidosis (pH < 7.20) via central and peripheral chemoreceptors. The patient mounts profound, rapid, deep hyperventilation (Kussmaul breathing) to eliminate carbon dioxide (PaCO2 < 20 mmHg), achieving compensatory respiratory alkalosis.
• HHS Hyperosmolar Cascade: Patients with Type 2 diabetes maintain minute residual basal insulin concentrations. While insufficient to facilitate skeletal muscle glucose uptake, this trace insulin is biochemically adequate to suppress adipose lipolysis and inhibit hepatic ketogenesis. Therefore, no significant ketoacidosis develops. Instead, uncontrolled hepatic gluconeogenesis drives plasma glucose to extreme levels (>33–60 mmol/L). Elevated glucose exceeds the renal reabsorption threshold (~10 mmol/L), producing massive osmotic diuresis (glucosuria), washing out vast volumes of water and electrolytes (sodium, potassium, magnesium). As water loss exceeds solute loss, serum osmolality climbs (>320 mOsm/kg), drawing water out of brain cells and causing profound dehydration and coma.

---

Prehospital Resuscitation Principles for DKA & HHS

Paramedics provide life-saving hemodynamic stabilization for both DKA and HHS focusing on fluid resuscitation:

1. Isotonic Crystalloid Fluid Resuscitation: The foundational prehospital intervention is intravenous 0.9% Normal Saline. Massive osmotic diuresis collapses intravascular volume, impairing renal perfusion and creating pre-renal azotemia. Paramedics administer an initial 1,000 mL bolus of normal saline over the first hour (or 10 to 20 mL/kg in pediatrics), followed by continuous reassessment of breath sounds, heart rate, and blood pressure to detect fluid overload.
2. Strict Prohibition of Prehospital Insulin: Primary care paramedics do NOT administer insulin in the field. Rapid prehospital insulin administration causes two lethal physiological disasters:
   • Catastrophic Hypokalemia: Insulin drives potassium into cells via the Na+/K+ ATPase pump. In DKA, total body potassium is severely depleted due to osmotic diuresis, even if serum potassium appears normal or elevated on initial lab work (due to extracellular shifting from acidosis). Injecting insulin without laboratory electrolyte confirmation and potassium replacement triggers sudden, fatal cardiac arrest from ventricular fibrillation or asystole.
   • Cerebral Edema: Rapid reductions in blood glucose drop plasma osmolality faster than brain idiogenic osmoles can dissipate. Water rushes down the osmotic gradient into brain parenchymal cells, causing fatal cerebral herniation, particularly in pediatric DKA patients.
3. Preserving Compensatory Hyperventilation: Paramedics must recognize that rapid, deep Kussmaul respirations in DKA are a vital compensatory mechanism to blow off CO2. Paramedics must never attempt to suppress this breathing or administer sedatives/narcotics, as blunting the respiratory rate traps CO2, causing profound acute drop in blood pH (pH < 6.9) and cardiac arrest.

---

Clinical Scenario: Hypoglycemic Stroke Mimic vs DKA

Paramedics respond to a 58-year-old male with Type 1 diabetes whose spouse called 911 reporting he is 'acting completely drunk, slurring his speech, and cannot move his right arm'.

1. Initial Presentation: The patient is seated at the kitchen table, pale, profusely diaphoretic, and confused. He is disoriented to time and place, has an asymmetrical right facial droop, and cannot raise his right arm against gravity. Initial thought by first responders is acute ischemic stroke.
2. Mandatory Glucometry: Prior to initiating any stroke bypass, the primary care paramedic performs a point-of-care capillary blood glucose test. The glucometer reads 'LOW' (<1.1 mmol/L).
3. Targeted Pharmacotherapy: The patient cannot follow commands or swallow safely, ruling out oral glucose gel. Paramedic 1 establishes an 18-gauge IV in the left forearm. Rather than administering hypertonic D50W, the paramedic connects a bag of 10% Dextrose in Water (D10W) and infuses 150 mL (15 grams of dextrose) over 5 minutes.
4. Rapid Reversal: Four minutes into the infusion, the diaphoresis resolves. The patient blinks, looks around, and asks what the paramedics are doing in his kitchen. Repeat physical examination reveals full resolution of the facial droop and equal 5/5 motor strength in both arms. Repeat capillary blood glucose is 5.4 mmol/L.
5. Post-Treatment Investigation: The patient recalls injecting his usual morning insulin but was delayed in eating breakfast due to a long phone call. The paramedic provides complex carbohydrates, conducts a full medical assessment, and safely transports the patient for clinical evaluation, having avoided an unnecessary and costly stroke bypass code.